Poor glycaemic control is associated with reduced serum free radical scavenging (antioxidant) activity in non-insulin-dependent diabetes mellitus

Annals of Clinical Biochemistry

Volumn 34, Issue 6, 1997, Pages 638-644

  Maxwell, S R J ^a,d   Thomason, H ^b   Sandler, D ^c   LeGuen, C ^b   Baxter, M A ^a,c   Thorpe, G H G ^b   Jones, A F ^c   Barnett, A H ^a,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Diabetic complications; Glycated haemoglobin; Oxidative stress; Uric acid

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; FREE RADICAL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; RETINOL; URIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SERUM; URIC ACID BLOOD LEVEL; VASCULAR DISEASE; VITAMIN BLOOD LEVEL;

EID: 0030772214     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329703400607     Document Type: Article

References (40)

1. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. Diabetologia 1978; 14: 363-70
2. Bierman EL. Atherogenesis in diabetes. Arterioscol Thromb 1992; 12: 647-56
3. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J. Beyond cholesterol - Modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24
4. Barnett AH. Pathogenesis of diabetic microangiopathy: an overview. American J Med 1991; 90 (suppl. 6A): 67-73
5. Brownlee M, Cerami A, Vlassara H. Advanced glycoslyation end-products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-21
6. Hunt JV, Bottoms MA, Mitchinson MJ. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Biochem J 1993; 291: 529-35
7. Jennings PE, Barnett AH. New approaches to the pathogenesis and treatment of diabetic microangiopathy. Diabetic Med 1988; 5: 111-7
8. Jones AF, Jennings PE, Wakefield A, Winkles JW, Lunec J, Barnett AH. The fluorescence of serum proteins in diabetic patients with and without retinopathy. Diabetic Med 1988; 5: 547-51
9. Stringer MD, Gorog PG, Freeman A, Kakkar VV. Lipid peroxides and atherosclerosis. BMJ 1989; 295: 281-4
10. Stocker R, Frei B. Endogenous antioxidant defences in human blood plasma. In: Sies H, ed. Oxidative Stress, Oxidants and Antioxidants. London: Academic Press, 1991
11. Sinclair AJ, Girling AJ, Gray L, LeGuen C, Lunec J, Barnett AH. Disturbed handling of ascorbic acid in diabetic patients with and without diabetic microangiopathy during high dose ascorbate supplementation. Diabetologia 1991; 34: 171-5
12. Sundram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci 1996; 90: 255-60
13. Maxwell SRJ, Thomason H, Sandler D, LeGuen C, Baxter MA, Thorpe GHG, et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Investig 1997 (in press)
14. Arai K, Iizuka S, Tada Y, Oikawa K, Taniguchi N. Increase in the glycosylated form of erythrocyte Cu-Zn-SOD in diabetes and the close association of non-enzymatic glycoslyation with enzyme activity. Biochim Biophys Acta 1987; 924: 292-6
15. Chen MS, Hutchinson ML, Pecoraro RE, Lee WYL, Labbe RF. Hyperglycaemia-induced intracellular depletion of ascorbic acid in human mononuclear leukocytes. Diabetes 1983; 32: 078-81
16. Standing SJ, Taylor RP. Glycated haemoglobin: an assessment of high capacity liquid chromatographic and immunoassay methods. Ann Clin Biochem 1992; 29: 494-505
17. Gochman N, Schmitz JM. Automated determination of uric acid, with use of a uricase-peroxidase system. Clin Chem 1971; 17: 1154-9
18. Whitehead TP, Thorpe GHG, Maxwell SRJ. An enhanced chemiluminescent assay for antioxidant capacity in biological fluids. Analytica Chim Acta 1992; 266: 265-77
19. Milne DB, Botnen J. Retinol, alpha-tocopherol, lycopene and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 1986; 32: 874-6
20. Thurnham DI, Davies JA, Crump BJ, Situnayake RD, Davis M. The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 1986; 23: 514-20
21. Nagy E, Degrell I. Determination of ascorbic acid and dehydroascorbic acid in plasma and cerebrospinal fluid by liquid chromatography with electrochemical detection. J Chromatog Biomed Applic 1989; 497: 276-81
22. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959; 82: 70-7
23. Nathan DM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 1984; 310: 341-6
24. Hunt SV, Dean RP, Wolff SP. Hydroxyl radical production and autooxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 1988; 256: 205-15
25. Azevedo M, Falcao J, Raposo J, Manso C. Superoxide radical generation by Amadori compound. Free Rad Res Commun 1988; 4: 331-5
26. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end-products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-21
27. Wolff SP, Dean RP. Glucose auto-oxidation and protein glycation. The potential role of autooxidative glycosylation in diabetes. Biochem J 1987; 245: 243-50
28. Collier A, Small M. The role of the polyol pathway in diabetes mellitus. Br J Hosp Med 1991; 45: 38-40
29. Davie SJ, Gould BJ, Yudkin JS. Effect of vitamin C on glycosylation of proteins. Diabetes 1992; 41: 167-73
30. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Torella R. A preliminary note on inhibiting effect of alpha-tocopherol (vitamin E) on protein glycation. Diabetes Metab 1988; 14: 40-2
31. Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Vitamin E reduction of protein glycosylation in diabetes. New prospects for prevention of diabetic complications? Diabetes Care 1991; 14: 68-72
32. Wayner DDM, Burton GW, Ingold KU, Barclay LRC, Locke SJ. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 1987; 924: 408-19
33. Ishihara M, Shinoda T, Aizawa T, Shirota T, Nagasawa Y, Yamada T. Hypouricaemia in NIDDM patients. Diabetes Care 1988; 11: 796-7
34. Erdberg A, Boner G, van Dyk DJ, Carel R. Urine uric acid excretion in patients with insulin-dependent diabetes mellitus. Nephron 1992; 60: 134-7
35. Ishihara M, Shinoda T, Yamada T. Co-occurence of hypercalciuria and hypouricaemia in type 2 diabetic patients. Diabetic Med 1989; 6: 406-11
36. Magoula T, Tsapas G, Paletas K, Mavromatidis K. Insulin-dependent diabetes and renal hypouricaemia. Nephron 1991; 59: 21-6
37. Grootveld M, Halliwell B. Measurement of allantoin and uric acid in human body fluids. Biochem J 1987; 243: 803-8
38. Jitapunkul S, Chalaprawat M, Bunnag S, Bhuvanpanich S, Kangkaya V, Pasatrat S, et al. The relationship between glucose and uric acid metabolism: influence of short term allopurinol on glucose metabolism. J Med Assoc Thailand 1991; 74: 80-6
39. Frei B, Stocker R, Ames BN. Antioxidant defences and lipid peroxidation in human blood plasma. Proc Nat Acad Sci 1988; 85: 9748-52
40. Basu TK, Tze WJ, Leichter J. Serum vitamin A and retinol-binding protein in patients with insulin-dependent diabetes mellitus. Am J Clin Nutrit 1989; 50: 329-31